Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients
Open Access
- 1 October 2003
- journal article
- research article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 15 (5) , 314-317
Abstract
The association between different antihypertensive drugs and erectile dysfunction (ED) was examined in a cohort of type II diabetes patients identified in the UK General Practice Research Database (GPRD). The GPRD contains details of diagnoses, prescribing, investigations, risk factors, outcomes, and hospital referrals, together with basic demographic information for approximately six million patients from more than 450 representative general practices throughout the UK. A total of 634 cases and 2526 controls were included for analysis. Unconditional logistic regression analysis was performed to assess the risk of ED after adjusting for age at diabetes diagnosis date, cigarette smoking, depression, glycemic control, use of HMG-CoA reductase inhibitors, use of histamine receptor antagonists, use of digitalis medicines, and use of nitrates. Increased risk of ED was observed among patients taking the following antihypertensives: ACE inhibitors (OR=1.47, 95% CI=1.21, 1.80) and alpha blockers (OR=1.54, 95% CI=1.11, 2.12). However, we identified a nearly 30% reduction in risk among patients on diuretics (OR=0.73, 95% CI=0.54, 0.99). No statistically significant increase in risk was observed among users of beta blockers and calcium channel blockers (OR=1.05, 95% CI=0.85, 1.31) and (OR=1.14, 95% CI=0.91, 1.43), respectively. The results of this study confirm the strong and recognized effect of comorbidities in a diabetic population, but also require additional experimental and observational studies to further understand the potential benefit of diuretics and other ED treatments such as PDE5 inhibitors.Keywords
This publication has 20 references indexed in Scilit:
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and WomenHypertension, 1997
- Further validation of information recorded on a general practitioner based computerized data resource in the united kingdomPharmacoepidemiology and Drug Safety, 1992
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991
- Sexual Symptoms in Hypertensive PatientsArchives of internal medicine (1960), 1988
- The Relevance of Intrinsic Sympathomimetic Activity for β-Blocker-Induced Changes in Plasma LipidsJournal of Cardiovascular Pharmacology, 1983
- Sexual dysfunction associated with oral antihypertensive medication: A critical survey of the literatureGeneral Hospital Psychiatry, 1982
- Sexual dysfunction with beta-blocker therapy: More common than we think?Sexuality and Disability, 1982
- ADVERSE REACTIONS TO BENDROFLUAZIDE AND PROPRANOLOL FOR THE TREATMENT OF MILD HYPERTENSIONThe Lancet, 1981
- Propranolol and Sexual ImpotenceAnnals of Internal Medicine, 1977